Shedding light on ADAM metalloproteinases

被引:371
|
作者
Huovila, APJ
Turner, AJ
Pelto-Huikko, M
Kärkkäinen, L
Ortiz, RM
机构
[1] Univ Tampere, Inst Med Technol, FIN-33520 Tampere, Finland
[2] Tampere Univ Hosp, FIN-33520 Tampere, Finland
[3] Univ Leeds, Sch Biochem & Microbiol, Proteolysis Res Grp, Leeds LS2 9JT, W Yorkshire, England
[4] Univ Tampere, Sch Med, Dept Dev Biol, Tampere 33014, Finland
[5] Univ Tampere, Sch Med, Dept Pathol, Tampere 33014, Finland
[6] Tampere Univ Hosp, Tampere 33014, Finland
基金
英国惠康基金;
关键词
D O I
10.1016/j.tibs.2005.05.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ADAM metalloproteinase disintegrins have emerged as the major proteinase family that mediates ectodomain shedding, the proteolytic release of extracellular domains from their membrane-bound precursors. Recent gene-manipulation studies have established the role of ADAM-mediated shedding in mammalian physiology and, in addition, raised the issue of functional redundancy among ADAM sheddases. ADAM sheddases activate, for example, growth factors and cytokines, thus regulating signalling pathways that are important in development and pathological processes such as cancer. The recent studies have also begun to elucidate the substrate specificity and the mechanisms that control ADAM-mediated shedding events that regulate, for example, growth-factor and Notch signalling, and the processing of the amyloid precursor protein.
引用
收藏
页码:413 / 422
页数:10
相关论文
共 50 条
  • [1] The ADAM metalloproteinases
    Edwards, Dylan R.
    Handsley, Madeleine M.
    Pennington, Caroline J.
    MOLECULAR ASPECTS OF MEDICINE, 2008, 29 (05) : 258 - 289
  • [2] Controlled shedding of platelet glycoprotein (GP)VI and GPIb-IX-V by ADAM family metalloproteinases
    Gardiner, E. E.
    Karunakaran, D.
    Shen, Y.
    Arthur, J. F.
    Andrews, R. K.
    Berndt, M. C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1530 - 1537
  • [3] Shedding Light on COVID-19: ADAM17 the Missing Link?
    Schreiber, Brittany
    Patel, Ankit
    Verma, Ashish
    AMERICAN JOURNAL OF THERAPEUTICS, 2021, 28 (03) : E358 - E360
  • [4] In silico studies of the metalloproteinases ADAM10 and ADAM 17
    Lindfors, Gunnar
    Caine, Sean
    Healy, Eamonn F.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [5] ADAM Metalloproteinases as Potential Drug Targets
    Camodeca, Caterina
    Cuffaro, Doretta
    Nuti, Elisa
    Rossello, Armando
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (15) : 2661 - 2689
  • [6] The emerging role of ADAM metalloproteinases in immunity
    Lambrecht, Bart N.
    Vanderkerken, Matthias
    Hammad, Hamida
    NATURE REVIEWS IMMUNOLOGY, 2018, 18 (12) : 745 - 758
  • [7] The emerging role of ADAM metalloproteinases in immunity
    Bart N. Lambrecht
    Matthias Vanderkerken
    Hamida Hammad
    Nature Reviews Immunology, 2018, 18 : 745 - 758
  • [9] A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10
    Parkin, Edward
    Harris, Benjamin
    JOURNAL OF NEUROCHEMISTRY, 2009, 108 (06) : 1464 - 1479
  • [10] Role of ADAM and ADAMTS metalloproteinases in airway diseases
    Genevieve Paulissen
    Natacha Rocks
    Maud M Gueders
    Celine Crahay
    Florence Quesada-Calvo
    Sandrine Bekaert
    Jonathan Hacha
    Mehdi El Hour
    Jean-Michel Foidart
    Agnes Noel
    Didier D Cataldo
    Respiratory Research, 10